X-linked chronic granulomatous disease (CGDI is due to mutations in the gp9lphox gene on Xp21.1. Studies in white and Japanese X-linked CGD patients have shown mutations in nearly every exon. We studied the molecular defect of seven Chinese patients with X-linked CGD from six unrelated families. Mutations were located by single-strand conformation polymorphism and then defined by sequence analysis.
The mutations were two different amino acid substitutions, a nonsense mutation, an in-frame trinucleotide deletion, a single A insertion causing a frameshift, and a premature stop. Lastly, a rare splice site mutation caused by G to A HRONIC GRANULOMATOUS disease (CGD) is an C uncommon primary immunodeficiency, affecting about 1 in 250,000 to 1,OOO,OOO individuals, with reported frequencies varying greatly in different countries.',' The estimated prevalence in Hong Kong Chinese is about 1 in 600,000. Patients are prone to recurrent life-threatening bacterial and fungal infections from early childhood. Polymorphonuclear leukocytes from CGD patients fail to produce superoxide anions (02 --) by NADPH oxidase.' Superoxide anion is a reactive free radical that kills invading microorganisms by a nonspecific oxidative process and is converted to other microbicidal agents, such as hypochlorous ion (OCl-), hydrogen peroxide (H,O,), and chloramine, by other enzyme system^.^ NADPH oxidase comprises five protein subunits: gp91phox and p22phox are situated on plasma and granular membranes, forming the cytochrome bsss heterodime?'; p47ph0x.~ p67phox,'O and the recently identified p40ph5~l'-~~ are cytosolic proteins that assemble with the cytochrome upon activation of the polymorphs. gp9lphox gene at chromosomal location Xp21.1 was cloned in 1986. 6 The gene spans about 30 kb and is divided into 13 exons. There are 569 amino acids in the predicted translation product, which is a highly glycosylated transmembrane protein. Mutations of the gp9lphox gene cause X-linked CGD, which accounts for about 65% of all reported CGD cases.I4 Mutations in white and Japanese patients have been r e p~r t e d .~. '~-~~ We describe here mutations in the gp9 lphox gene in seven Chinese male patients with X-linked CGD from six unrelated families. Nitroblue tetrazolium (NBT) tests showed the complete absence of superoxideproducing ability in leukocytes from all seven patients. Single-strand conformation polymorphism (SSCP) and sequencing of their genomic DNA and/or cDNA were performed. Six different mutations were identified.
MATERIALS AND METHODS
Patients. All seven patients were diagnosed by the absence of reduction of NBT. Clinical features of six of them have been reported previou~ly.~~ The mothers of patients no. 1, 2, 4, and 7 and the sisters of patients no. 4 and 5 were included in our study.
Genomic DNA was isolated by sodium chloride as described by Miller et al?4 Total RNA was prepared from ficoll isolated white blood cells by lysis with 4 m o w guanidinium thiocyanate followed by phenokhloroform extraction, as described by Chomczynski and Sa~chi. ' [voVvol] formamide), denatured at 90°C for 10 minutes, and then chilled on ice. A 4-pL aliquot was loaded onto a nondenaturing 5% polyacrylamide, 5% glycerol, l x TBE (89 mmolL Tris-Borate, 20 mmol/L EDTA, pH 8.3) gel and electrophoresed at 900 V at room temperature (7E25"C) for 5 hours or at 500 V at room temperature overnight. Gels were transferred to Whatman 3MM paper (Whatman, Maidstone, UK), dried, and visualized by autoradiography after 20 to 24 hours of exposure.
Three pairs of primers SSCP analysis.
Reverse transcription-PCR (RT-PCR).
(1L-5'CCCAGGGCTGAT3'/1R--SfCAAAGTAAGA 
RESULTS
Patients' mRNA samples were reverse transcribed into three overlapping cDNA fragments, PCR amplified, and analyzed by agarose gel electrophoresis. Similarly, all 13 exons (including the exonhtron boundary sequences) of the gp9Ip/io.x gene were PCR-amplified for agarose gel and SSCP analysis.
PCR of cDNA fragments and exons of patients no. 1 through 6 obtained products with normal lengths, showing that their mutations are not large chromosomal aberrations or splice errors. Patient no. 1 showed an abnormal mobility shift in exon 9. Sequence analysis showed a point mutation of TI037 + A (Leu342 + Glu). Patient no. 1's mother showed her carrier status by showing both the wild-type allele (T) and the mutant allele (A) at nucleotide 1037 (Fig  1) . Patient no. 2 was affected by an in-frame trinucleotide deletion of TTC (nucleotides 652 to 654 or 655 to 657) coding for Phe215 or 216 in exon 6 (Fig 2) . The patient's mother showed an overlapped sequence of the wild-type and the deleted sequence by sequencing (data not shown), Fig  3) . Patients no. 4 and 5 (brothers) had a single A insertion between A749 to A754 in exon 7 (Fig 4) . Their mother had both the wild-type sequence and the A inserted sequence, but their sister had only the wild-type sequence. Patient no.
6 was affected by a nonsense mutation caused by a G 1567 T transversion, which changed the amino acid Glu519 to a stop codon (TAA). However, his mother's sequence showed the wild-type allele only, confirming her normal NBT test result (Fig 5) .
RT-PCR of patient no. 7's mRNA gave a smaller 5'
cDNA fragment (~5 9 0 bp). whereas his mother gave both the smaller and the normal 5' fragments (694 bp), showing her carrier status. The middle and 3' cDNA fragments were of normal sizes. PCR products of the patient's exons were also normal, showing that the smaller 5' cDNA fragment was not the result of deletion in his gene. A splice error was therefore deduced. SSCP and sequence analysis of patient no. 7 found a silent mutation of (3264 + A transition at the exon 3 terminal position. To investigate whether this point mutation caused deletion in his cDNA fragment, the cDNA fragment was sequenced. It showed that exon 4 joined directly to exon 2, whereas the whole exon 3 (1 1 1 bp) was absent. This point mutation at the -1 position of the 5' splice site of intron 3 therefore caused a splice error (Fig 6) .
The six mutations we identified were tabulated in Table 2 .
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DISCUSSION
We identified six different mutations in the gp9lphox gene causing X-CGD in seven Chinese patients diagnosed by the complete absence of NBT function. Delineation of the gp9lplio.v protein structure is important in elucidating the NADPH oxidase assembly mechanism and its activation pathway and, in turn, explains the possible effect of mutations on the function of the protein in X-linked CGD patients. Hence, mutations in gp9lphox will provide evidence for or against certain models of the protein or proteins with similar structural domains. However, due to the lack of crystallographic data of the membraneous heterodimeric cytochrome h558. its tertiary structure remains obscure. Roos et al' and Parkos et al" proposed two hypothetical models for the gp9lphox. They are very similar to each other except for the location of the second helix. Roos et al' suggested that amino acids within Ser48 and Phe78 in exon 3 formed the second transmembrane helix. However, significant experimental evidence supporting this structural speculation is lacking. For personal use only. on October 23, 2017. by guest www.bloodjournal.org From nucleation center for folding other domains that binds other parts of FAD or NAD. Clues for explanation of this TTC trinucleotide deletion may be found by examining sequence around the trinucleotide. The deleted TK trinucleotide is included in a direct repeat of l T C ; therefore, polymerase slippage during DNA replication may account for its deletion. In addition, a deletion hotspot consensus TGAAGA identified by Krawczak and Cooper4' is found in the noncoding DNA strand partially overlapping with the deletion.
The effect of a conserved amino acid change of Phe205 + Ile found in patient no. 3 was difficult to interpret. Although it is near the &p-fold for FAD binding and the histidine residues for heme binding, the devastating effect resulted from this mutation could not be easily explained on the present model. Based on the structural models, FZo5WYzo7 marks the beginning of the fourth transmembrane helix. A possible function of these amino acids is to anchor the helix in the membrane in the correct orientation, because clusters of aromatic residues are present at the polarhonpolar interface of transmembrane helix in other membraneous prot e i n~.~* The absence of Phe205 may hence affect the stability of the protein through the inability to maintain the correct orientation or position of the transmembrane helix. In addition, if histidine residues at 209 and 210 are ligands of a heme group, the proper position of the helix will be important for holding the heme or for providing a microenvironment to maintain its oxidation-reduction potential.
A single A insertion within the run of As from nucleotide 749 to 754 in exon 7 was found in patients no. 4 and 5 (brothers). Another similar insertion of an A in a tandem of five As from nucleotide 768 to 772 in exon 7 had been rep~rted."~ In both cases, a frameshift and a premature stop codon was expected in exon 8. Similarly, insertion of the same nucleotide in a run of the nucleotide was found in several disease genes, eg, in hypoxanthine-gumme phosphoribosyl transferase (HPRT) gene causing Lesch-Nyhan syndrome, which caused a plusone frameshift, has been Insertions in these two closely situated tandem A sequences may therefore indicate a high incidence of slippage during DNA replication process. One case of the A insertion within A749 to A754 was found in the nether land^,^^ and six unrelated cases were found in the United States by Dr J.T. C~r n u t t e~~ (personal communication, April 1996). These eight cases represent the largest number of the same mutations ever found in X-linked CGD and this region may be a mutation hotspot for the gp9lphox gene. A nonsense mutation was found in patient no. 6; the change of G1567 + T in exon 12 created a TAA stop codon. Because patient no. 6's mother is not a carrier, this mutation may arise in the germline of his mother or is a spontaneous mutation in the patient. The truncated gp9lphox protein produced in patients no. 4 through 6 was expected to be nonfunctional because of loss of peptide sequences for FAD, NADPH, and p47phox binding.
The point mutation of G + A at the terminal position of exon 3 of patient no. 7 caused an unexpected splice error and the exon 3 was spliced out in the patient's mRNA. This mutated G is at a CpG island, and it was also reported that four unrelated patients in European countries had the same mu&tion,4s indicating this may be the second mutation hotspot. Because exon 3 contains an integral number of codons, the splice error does not affect the reading frame. No amino acid sequence in exon 3 had been suggested as cofactor binding sites. However, according to Parkos et aL2' exon 3 was on the first intracellular domain in which a potential p47pho.x binding sequence was found. Exon 3 encoded amino acid sequence was essential for forming a particular local tertiary structure in the first intracellular domain for p47phox binding and p22phox intera~tion.4~ Absence of exon 3 would be detrimental, because interaction between gp9lphox and p22phox would stabilize each other. An alternative consequence of this mutation would produce a normal protein without amino acid change. The point mutation was at the wobble position of codon 84, where both the wild- 
Exon 6
In-frame trinucleotide deletion of TTG at nucleotide
652-654 or 655-657
Insert A within A749 to A754 Insert A within A749 to A754 G1567 + T G ( -l ) + A Skip exon 3
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From type GCG and the mutant GCA coded for an alanine. However, the normal cDNA was not detected by RT-PCR. The point mutation therefore severely affected the normal functioning of the 5' splice site.
This mutation is the ninth of this kind r e p~r t e d .~~.~' .~~ One of them was reported recently at the gp9lphox gene exon 5 terminal position. Others were found associated with different genetic disorders, causing complete or partial elimination of the affected 5' splice site functions. This inconsistent consequence provides evidence that not only the well-conserved GT dinucleotide and the sequences in the intron sequence, but also exon sequences help to determine the proper splice junction position and participate in splicing. Comparison of sequences around the nine mutated positions showed no common feature except the highly conserved nucleotides, implicating their random occurrence. In addition, Robberson et als4 hypothesized that recognizing exon boundaries (exon definition) rather than intron boundaries was the first step in spliceosome assembly. According to this hypothesis, failing to define the exon boundaries would cause an exon skipping, as seen in all nine mutations. This is in contrast to the theory of defining intron b~u n d e r i e s ,~~ which predicted an intron inclusion in case the splice sites were not recognized. The mutation found in patient no. 7 and the 7 mutations reported at the same position therefore provided strong evidence for Robberson et al's exon definition hypothesis.
All of the patients studied suffered from Xo-CGD subtype characterized by a complete absence of NADPH oxidase activity, suggesting that the protein has very low tolerance towards amino acid substitutions. Mutation analysis usually showed different mutations at different positions from unrelated patients. The six mutations we identified are located in five different exons of the gp9lphox gene and are unique to each family. This heterogeneous mutation spectrum is also found in white and Japanese CGD patients, so absence of ethnic group specific mutation is suggested.
The mutations we identified have shed light on the structure-function relationship of the gp9lphox protein. The importance of particular amino acid residues in cofactor binding sites is confirmed or implicated. The rare splice mutation also provided information in understanding the splicing mechanism. Furthermore, two mutation hotspots of the gp9lphox gene are suggested. 
